Selected Publications

1. Rodthongdee K, Watanapa WB, Ruamyod K, Semprasert N, Nambundit P, Kooptiwut S, Boontaveekul L*. Ginsenoside Re increases human coronary artery endothelial SKCa current and nitric oxide release via glucocorticoid receptor-PI3K-Akt/PKB pathway. J Ginseng Res. 2025 Sep;49(5):523-31. Epub 2025 Apr 29. doi: 10.1016/j.jgr.2025.04.008 [Impact factor 2023 = 6.8, 2024 = 5.6, Q1, Top 3]

2. Kulapatana S*, Diedrich A, Lersritwimanmaen P, Watanapa WB. Postural orthostatic tachycardia syndrome in a Thai male patient. Clin Auton Res. 2024; doi: 10.1007/s10286-024-01044-1 [Impact factor 2024 = 3.4, Q1]

3. Theerathananon W, Watanapa WB*, Wataganara T, Pratumvinit B, Rahman S. Preeclamptic serum and soluble fms-like tyrosine kinase-1 suppress endothelial inward rectifier potassium currents. Placenta. 2024 Feb; 146: 101-109. (Published online 11 Jan 2024; doi: 10.1016/j.placenta.2024.01.002) [Impact factor 2023 = 3.0, 2024 = 2.5, Q1]

4. Tipcome K, Watanapa WB*, Ruamyod K. Hesperetin relaxes depolarizing contraction in human umbilical vein by inhibiting L-type Ca2+ channel. Chin J Integr Med. 2024; doi: 10.1007/s11655-024-3713-1 [Impact factor 2024 = 2.5, Q2]

5. Somboon P, Kulapatana S, Watanapa WB*, Chattaris T, Sirivongrangson P, Livikorn P, Nonthadid T, Hussarin P. Heart rate variability and baroreflex sensitivity: factors and reference ranges. Siriraj Med J 2023;75(10):723-34. doi: 10.33192/smj.v75i10.264037 [Impact factor SJR 2023 = 0.18, Q4]

6. Ruamyod K, Watanapa WB*, Kakhai C, Nambundit P, Treewaree S, Wongsanupa P. Ferulic acid enhances insulin secretion by potentiating L-type Ca2+ channel activation. J Integr Med. 2023; 21(1): 99-105. (Epub 23 Nov 2022; doi: 10.1016/j.joim.2022.11.003) [Impact factor 2023 = 4.2, Q1]

7. Panchavinnin P, Wanthong S, Roubsanthisuk W, Tresukosol D, Buranakitjaroen P, Chotruangnapa C, Watanapa W, Pongakasira R, Wongpraparut N*. Long-term outcome of renal nerve denervation (RDN) for resistant hypertension. Hypertens Res. 2022; 45: 962-6. (Published online 07 Apr 2022; doi:10.1038/s41440-022-00910-7) [Impact factor 2022 = 5.4, Q1]